Skip to main content
. Author manuscript; available in PMC: 2022 Jan 25.
Published in final edited form as: Commun Med (Lond). 2021 Dec 9;1:60. doi: 10.1038/s43856-021-00060-w

Fig. 2. A comparison of HERV-K levels in FTD and ALS.

Fig. 2.

(A) HERV-K env levels in FTD (n = 63), ALS (n = 89) and control (n = 21) serum as measured by ddPCR. (B) HERV-W env levels in FTD (n = 63), ALS (n = 89) and control (n = 21) serum as measured by ddPCR. (C) HERV-K ROC curve for FTD v Con. (D) HERV-K ROC curve for ALS v Con. (E) HERV-K ROC curve for FTD v ALS. Data represent individual patients, mean and SE as error bars, **P < 0.01, ***P < 0.001, ****P < 0.000005.